MUNICH, Germany, April 26, 2022 (GLOBE NEWSWIRE) -- ViGeneron GmbH, a next-generation gene therapy company, today announced a follow-on ...
https://www.google.com/url?rct=j&sa=t&url=https://www.globenewswire.com/news-release/2022/04/26/2428712/0/en/ViGeneron-announces-follow-on-collaboration-with-Daiichi-Sankyo-to-develop-a-novel-gene-therapy-for-prevalent-eye-diseases.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw0lnGgQxjHCl_x2m2bryMix
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.